Navigation Links
Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C.
Date:9/23/2010

SAN LEANDRO, Calif., Sept. 23 /PRNewswire/ -- Preclinical data of a novel therapy designed to treat drug-resistant hypertension (high blood pressure) was presented Tuesday, September 21st, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 Conference in Washington, DC, by Christopher D. Owens, MD, MSc, Assistant Professor in Residence, Division of Vascular and Endovascular Surgery, University of California, San Francisco. The therapy pioneered by Mercator MedSystems, Inc., combines the use of the company's Bullfrog® Micro-Infusion Catheter with a known drug to reduce the hyperactivity of nerves in the renal artery leading to and from the kidney. These nerves are implicated in the initiation and maintenance of high blood pressure. The early data shows that this therapy precisely targets these nerves, achieving the desired effect without negatively affecting surrounding tissue. Dr. Owens observed, "While these data are early, the site-specific delivery of drugs directly to the nerves in question offers great promise for a new approach in treating the nearly one-third of 73 million U.S. hypertensive patients who cannot control their blood pressure with medication alone."

The company believes the procedure will take less than an hour in an outpatient setting. In it, the slender Micro-Infusion Catheter is introduced into an artery through a small needle in the upper leg, and is guided into the main kidney artery (the renal artery). Once positioned, a balloon at the tip of the catheter is inflated inside the artery, sliding a 130 micron (two hair widths thick) microneedle through the artery wall into the tissue known as the adventitia, which envelops the hyperactive nerves leading to the kidney. As the drug is infused through the microneedle, it surrounds the artery to create an effective cylindrical treatment zone and reduces the nerve signals which cause high blood pressure.

The company plans to initiate human investigational trials of th
'/>"/>

SOURCE Mercator MedSystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Promising Cystic Fibrosis Compound on Track for Development
2. Kiadis Pharma Announces Promising Phase II Clinical Trial Results for Reviroc
3. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
4. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
5. The Leukemia & Lymphoma Society is Encouraged by Promising News for Myeloma Patients
6. Promising Results in Treating Facial Bruising From Injectables
7. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
8. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
9. Cutanea Announces Promising Phase II Results in Rosacea with Omiganan
10. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
11. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... SEATTLE , BERKELEY, Kalifornien, und KOPENHAGEN, ... CMC Biologics, Inc. , ein Weltmarktführer der ... und anderen therapeutischen Proteinen, gab heute bekannt, ... Expansionsstrategie der Produktionskapazität den Ausbau der nordamerikanischen ... , mit der Ergänzung  einer Einweg-Anlage Bioreactor ...
(Date:6/30/2015)... June 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... public offering  of 40,229,886 units. Each unit consists of ... A warrant to purchase one share of common stock, ... one share of common stock, at a purchase price ...
(Date:6/30/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ... company focused on developing, manufacturing and marketing ... from a Category 3 human abuse liability ... oral oxycodone product candidate in late-stage clinical ... enough to require daily, around-the-clock opioid treatment ...
Breaking Medicine Technology:CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 2Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 3Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 4Egalet Announces Top-Line Results from Oral Human Abuse Liability Study of Egalet-002 5
... YONKERS, N.Y., Sept. 27, 2011 As a result ... that could be dangerous to their health, according to ... Americans who currently take a prescription medicine told pollsters ... a doctor,s visit or medical procedure, declining tests, or ...
... Pa., Sept. 27, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... development of synthetic immunogens against cancers and infectious diseases, ... Research and Development Agreement (CRADA) with the United States ... Plum Island Animal Disease Center. This collaboration will evaluate ...
Cached Medicine Technology:Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 2Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 3Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 4Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 5Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 2Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 3Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines' Potential to Help Ensure Nation's Food Supply Safety 4
(Date:6/30/2015)... ... June 30, 2015 , ... Dr. Sammy Masri of Masri Sports Medicine ... specializes in the diagnosis and treatment of non-surgical sports and other musculoskeletal injuries for ... in recreational athletics and use exercise to stay healthy and active. Dr. Masri seeks ...
(Date:6/30/2015)... ... June 30, 2015 , ... MJH Associates ... HRA Healthcare Research & Analytics , a consultative healthcare market research practice that ... of businesses. HRA offers quantitative and qualitative, custom and multi-client primary market research ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... are partnering to improve access to cancer prevention, screening and care for the ... have announced an affiliation that will see Roswell Park faculty providing clinical consultations ...
(Date:6/30/2015)... NY (PRWEB) , ... June 30, 2015 , ... New ... New York July 7th and 11th 2015. Timber frame post and beam raisings offer ... , “Raising a timber frame is an important and exciting event ...
(Date:6/30/2015)... ... June 30, 2015 , ... LifeAID Beverage Company has ... leading organizations dedicated to raising worldwide awareness of the burgeoning “adaptive” movement, I ... now the official charity of FitAID. I AM ADAPTIVE is a non-profit whose ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 2Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 4Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3
... STAAR Surgical Company (Nasdaq: STAA ), ... ophthalmic products, today announced the approval of the KS-Ni ... regulatory authorities. , , The KS-Ni Preloaded Silicone ... Japan,s blue-blocker silicone IOL through an incision size of ...
... ... enroll in the plan that is best for them and receive significant healthcare savings; ... ... has expanded the Allsup Medicare Advisor(SM) service to help people best evaluate their Medicare ...
... ... HealthForumOnline (HFO), announces the addition of a new online CE/CEU ... and Their Families, to our extensive resource library for mental health ... with intellectual and developmental disorders (IDD) is steadily increasing, largely due ...
... 17 , , , , ... , Outstanding Debt to be Reduced by Approximately $54.8 ... Approximately $3.4 Million , Company to Book Approximately ... Equity to Increase by Approximately $45.4 Million , , , ...
... Characterizes FDA Action as Unwarranted, Withdraws Two Cold Remedy Nasal ... Ariz. , June 16 Matrixx Initiatives, Inc. (Nasdaq: ... warning letter today from the U.S. Food and Drug Administration ... Cold Remedy Nasal Gel and Zicam Cold Remedy Swabs. The ...
... change" says new leader of American medicine , , ... cardiologist from Bryan, Texas, was inaugurated today as the 164th ... and most influential physician organization. , , (Logo: ... In his inaugural address as AMA president, Dr. Rohack spoke ...
Cached Medicine News:Health News:STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System 2Health News:STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System 3Health News:Allsup Medicare Advisor(SM) Expands Service; Helps Seniors and People with Disabilities Make Best Medicare Choices 2Health News:Allsup Medicare Advisor(SM) Expands Service; Helps Seniors and People with Disabilities Make Best Medicare Choices 3Health News:Allsup Medicare Advisor(SM) Expands Service; Helps Seniors and People with Disabilities Make Best Medicare Choices 4Health News:Allsup Medicare Advisor(SM) Expands Service; Helps Seniors and People with Disabilities Make Best Medicare Choices 5Health News:Autism Course Added to HealthForumOnline's Continuing Education (CE) Website for Mental Health Professionals & Nurses 2Health News:Autism Course Added to HealthForumOnline's Continuing Education (CE) Website for Mental Health Professionals & Nurses 3Health News:Autism Course Added to HealthForumOnline's Continuing Education (CE) Website for Mental Health Professionals & Nurses 4Health News:Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 2Health News:Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 3Health News:Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding 4Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 3Health News:AMA Inaugurates J. James Rohack as President 2
... Integra II SP MRI-Compatible Anesthesia System is perfect ... more than one type of anesthetic agent. ... and due to its wider stance, has a ... ventilator bellows assembly is utilized in both the ...
... Market leader in soft tissue repair in ... has developed the latest evolution in orthopedic ... ORTHOCORD Suture is as strong as any ... importantly, ORTHOCORD Suture handles like ETHIBOND®., ,ORTHOCORD ...
... PURPLE NITRILE* product family offers a comprehensive ... gloves were designed as an alternative for ... hypersensitivity to natural rubber latex proteins. The ... from latex and other synthetic gloves. Custom ...
... and the distinctive COLOR PURPLE* distinguish ... them for sterile clinical procedures when ... required. Theyre designed as an alternative ... Type 1 hypersensitivity to natural rubber ...
Medicine Products: